Kie Sekiguchi, Takaya Abe, Ei Shiomi, Daiki Ikarashi, Tomohiko Matsuura, Shigekatsu Maekawa, Renpei Kato, Mitsugu Kanehira, Ryo Takata, Jun Sugimura, et al. Abnormal carnitine metabolism in hemodialysis patients on different anticoagulants. Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy. 2024. 28. 3. 364-370
Shigekatsu Maekawa, Ryo Takata, Kie Sekiguchi, Masahiro Kagabu, Moe Toyoshima, Shinji Tamada, Kenta Takahashi, Daiki Ikarashi, Tomohiko Matsuura, Renpei Kato, et al. Prevalence of germline BRCA1/2 pathogenic variants in Japanese patients treated with castration-resistant prostate cancer and efficacy of CRPC treatment in real-world clinical practice. Japanese journal of clinical oncology. 2024. 54. 4. 489-497
Kenta Takahashi, Renpei Kato, Daiki Ikarashi, Tomohiko Matsuura, Shigekatsu Maekawa, Mitsugu Kanehira, Ryo Takata, Jun Sugimura, Takaya Abe, Wataru Obara. Avelumab plus axitinib for translocation renal cell carcinoma: A case series and literature review. IJU case reports. 2024. 7. 2. 131-135
Moe Toyoshima, Daiki Ikarashi, Hiroyuki Tsuboi, Makoto Moriwaka, Shinji Tamada, Tomohiko Matsuura, Shigekatsu Maekawa, Renpei Kato, Mitsugu Kanehira, Ryo Takata, et al. [A Case of Metastatic Renal Cell Carcinoma with Arthritis and Colitis Due to Immune-Related Adverse Events During Ipilimumab-Nivolumab Combination Therapy]. Hinyokika kiyo. Acta urologica Japonica. 2023. 69. 8. 227-232
Ei Shiomi, Renpei Kato, Mitugu Kanehira, Ryo Takata, Jun Sugimura, Yasuyuki Nakamura, Takashi Ujiie, Takaya Abe, Wataru Obara. Cribriform pattern in prostate tissues: Predictor for intraductal carcinoma of the prostate based on biopsy and radical prostatectomy pathology. BJUI compass. 2023. 4. 3. 339-345
Yoichiro Kato, Hitoshi Zembutsu, Ryo Takata, Tomohiko Matsuura, Renpei Kato, Mitsugu Kanehira, Kazuhiro Iwasaki, Jun Sugimura, So Omori, Takaya Abe, et al. SELECTIVE NEOADJUVANT CHEMOTHERAPY BY PREDICTION SYSTEMS IMPROVES THE CHEMO-SENSITIVITY OF THE MUSCLE INVASIVE BLADDER CANCERS. JOURNAL OF UROLOGY. 2016. 195. 4. E669-E669
Daiki Ikarashi, Yoichiro Kato, Mitsugu Kanehira, Ryo Takata, Misato Takayama, Akito Ito, Mitsutaka Onoda, Renpei Kato, Tomohiko Matsura, Kazuhiro Iwasaki, et al. PREOPERATIVE MEMBRANOUS URETHRAL LENGTH BECOMES PREDICT FACTOR FOR THE EARLY URINARY INCONTINENCE AFTER ROBOT ASSISTED LAPAROSCOPIC RADICAL PROSTATECTOMY. JOURNAL OF UROLOGY. 2016. 195. 4. E315-E315
Ryo Takata, Takashi Nasu, Wataru Obara, Taisei Mushiroda, Michiaki Kubo, Hidewaki Nakagawa, Yusuke Nakamura, Tomoaki Fujioka. IMPACT OF POLYMORPHISMS IN ABCB1 AND NRI2 WITH DOCETAXEL RESPONSE FOR CASTRATION-RESISTANT PROSTATE CANCER. JOURNAL OF UROLOGY. 2014. 191. 4. E508-E509
Yoichiro Kato, Hitoshi Zembutsu, Ryo Takata, Kazuhiro Iwasaki, Wataru Obara, Yusuke Nakamura, Tomoaki Fujioka. A PROSPECTIVE STUDY TO EXAMINE THE AVAILABILITY OF THE PREDICTION SYSTEM OF NEOADJUVANT CHEMOTHERAPY FOR MUSCLE INVASIVE BLADDER CANCER. JOURNAL OF UROLOGY. 2013. 189. 4. E589-E590
Shusuke Akamatsu, Ryo Takata, Atsushi Takahashi, Michiaki Kubo, Christopher Haiman, Brien Henderson, Tomoaki Fujioka, Tomonori Habuchi, Yusuke Nakamura, Osamu Ogawa, et al. A COMMON GENETIC VARIANTS BASED RISK PREDICTION MODEL FOR PROSTATE CANCER IS HIGHLY REPRODUCIBLE IN JAPANESE, AND COMPENSATES FOR PROSTATE SPECIFIC ANTIGEN AT GRAY-ZONE. JOURNAL OF UROLOGY. 2013. 189. 4. E916-E916
